- Home
- ALVR vs KZR Comparison
ALVR vs KZR Comparison
Compare ALVR & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- KZR
- Stock Information
- Founded
- ALVR 2013
- KZR 2015
- Country
- ALVR United States
- KZR United States
- Employees
- ALVR N/A
- KZR N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- ALVR Health Care
- KZR Health Care
- Exchange
- ALVR Nasdaq
- KZR Nasdaq
- Market Cap
- ALVR 46.6M
- KZR 46.5M
- IPO Year
- ALVR 2020
- KZR 2018
- Fundamental
- Price
- ALVR $9.38
- KZR $6.33
- Analyst Decision
- ALVR
- KZR Hold
- Analyst Count
- ALVR 0
- KZR 2
- Target Price
- ALVR N/A
- KZR $9.00
- AVG Volume (30 Days)
- ALVR 29.1K
- KZR 48.3K
- Earning Date
- ALVR 03-14-2025
- KZR 03-13-2025
- Dividend Yield
- ALVR N/A
- KZR N/A
- EPS Growth
- ALVR N/A
- KZR N/A
- EPS
- ALVR N/A
- KZR N/A
- Revenue
- ALVR N/A
- KZR N/A
- Revenue This Year
- ALVR N/A
- KZR N/A
- Revenue Next Year
- ALVR N/A
- KZR N/A
- P/E Ratio
- ALVR N/A
- KZR N/A
- Revenue Growth
- ALVR N/A
- KZR N/A
- 52 Week Low
- ALVR $7.96
- KZR $5.20
- 52 Week High
- ALVR $24.15
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- ALVR 39.33
- KZR 42.57
- Support Level
- ALVR $7.96
- KZR $6.16
- Resistance Level
- ALVR $10.00
- KZR $6.63
- Average True Range (ATR)
- ALVR 1.14
- KZR 0.28
- MACD
- ALVR 0.03
- KZR -0.01
- Stochastic Oscillator
- ALVR 35.50
- KZR 23.08
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.